Fortress Biotech Just Netted $159 Million - Its Preferred Shares Could Be The Real Winner
Fortress Biotech Inc FBIO
$3.13
▼ -4.86%
($-0.16)
⬇️ Below Yest. Low
🔥 High Short Interest
🗓️ Earnings Next Week
Open
$3.28
Prev Close
$3.29
Day Range
$3.08 – $3.28
52W Range
$1.77 – $4.53
Market Cap
$103.98M
P/E (TTM)
0.81
Beta
1.19
EPS (TTM)
$3.44
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2011-11-17 |
| Shares Out. | 33,220,000 |
| Website | fortressbiotech.com/ ↗ |
| Phone | 17816524500 |
| Employees | 78 |
| Revenue | $15.9M |
| Gross Profit | $9.7M |
| Net Income | $137.2M |
| Total Assets | $356.9M |
| Total Liabilities | $154.5M |
| Equity | $202.4M |
About Fortress Biotech Inc
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Fortress Biotech Inc is a publicly traded company under the ticker symbol FBIO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)